Literature DB >> 14500667

IFN-gamma-independent effects of IL-12 during intestinal nematode infection.

Helena Helmby1, Richard K Grencis.   

Abstract

Expulsion of the gastrointestinal nematode Trichinella spiralis is associated with a pronounced mastocytosis mediated by a Th2-type response involving IL-4, IL-10, and IL-13. When exogenous rIL-12 was administered to T. spiralis-infected NIH mice, this resulted in significant suppression of intestinal mast cell responses, delayed worm expulsion, increased muscle larvae burdens, and a transient, but significant decrease in early Th2 cytokine secretion. rIL-12 treatment also altered chemokine expression in the jejunal mucosa. The effects of exogenous IL-12 administration were largely independent of IFN-gamma as shown by rIL-12 treatment of IFN-gamma knockout mice. Hence, IL-12 may play a significant biological role as a direct negative regulator of intestinal Th2 responses and may act to promote the survival of intestinal parasites in vivo also in the absence of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500667     DOI: 10.4049/jimmunol.171.7.3691

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  The impact of anthelminthic therapeutics on serological and tissues apoptotic changes induced by experimental trichinosis.

Authors:  Samia E Etewa; Ghada M Fathy; Sara A Abdel-Rahman; Dalia Abd El-Khalik; Mohamed H Sarhan; Maha S Badawey
Journal:  J Parasit Dis       Date:  2018-03-26

Review 2.  Role of helminths in regulating mucosal inflammation.

Authors:  Joel V Weinstock; Robert W Summers; David E Elliott
Journal:  Springer Semin Immunopathol       Date:  2005-06-15

3.  Inhibition of nitric oxide production by aminoguanidine influences the number of Trichinella spiralis parasites in infected "low responders" (C57BL/6) and "high responders" (BALB/c) mice.

Authors:  Marta Kołodziej-Sobocińska; Ewa Dziemian; Barbara Machnicka-Rowińska
Journal:  Parasitol Res       Date:  2006-03-16       Impact factor: 2.289

4.  Participation of MyD88 and interleukin-33 as innate drivers of Th2 immunity to Trichinella spiralis.

Authors:  Lisa K Scalfone; Hendrik J Nel; Lucille F Gagliardo; Jody L Cameron; Shaikha Al-Shokri; Cynthia A Leifer; Padraic G Fallon; Judith A Appleton
Journal:  Infect Immun       Date:  2013-02-12       Impact factor: 3.441

Review 5.  Context-dependent roles of B cells during intestinal helminth infection.

Authors:  Aidil Zaini; Kim L Good-Jacobson; Colby Zaph
Journal:  PLoS Negl Trop Dis       Date:  2021-05-13

Review 6.  Trichinella inflammatory myopathy: host or parasite strategy?

Authors:  Fabrizo Bruschi; Lorena Chiumiento
Journal:  Parasit Vectors       Date:  2011-03-23       Impact factor: 3.876

Review 7.  Therapeutic Effects of Resiniferatoxin Related with Immunological Responses for Intestinal Inflammation in Trichinellosis.

Authors:  José Luis Muñoz-Carrillo; José Luis Muñoz-López; José Jesús Muñoz-Escobedo; Claudia Maldonado-Tapia; Oscar Gutiérrez-Coronado; Juan Francisco Contreras-Cordero; María Alejandra Moreno-García
Journal:  Korean J Parasitol       Date:  2017-12-31       Impact factor: 1.341

8.  Serglycin proteoglycans limit enteropathy in Trichinella spiralis-infected mice.

Authors:  Ananya Roy; Osama Sawesi; Ulrika Pettersson; Anders Dagälv; Lena Kjellén; Anna Lundén; Magnus Åbrink
Journal:  BMC Immunol       Date:  2016-06-08       Impact factor: 3.615

9.  Intraperitoneal administration of the anti-IL-23 antibody prevents the establishment of intestinal nematodes in mice.

Authors:  M Gomez-Samblas; D Bernal; A Bolado-Ortiz; S Vilchez; F Bolás-Fernández; A M Espino; M Trelis; A Osuna
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

10.  Biodegradable Chitosan Decreases the Immune Response to Trichinella spiralis in Mice.

Authors:  Klaudia Brodaczewska; Natalia Wolaniuk; Katarzyna Lewandowska; Katarzyna Donskow-Łysoniewska; Maria Doligalska
Journal:  Molecules       Date:  2017-11-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.